Acquisition / mergerFiled on BSE ·
Maithan Alloys Limited acquires 2,527,000 shares of HFCL Limited on 1st Oct 2026
Maithan Alloys Ltd · Ferrous Metals
What the filing says
- Acquired 0.17% shareholding in HFCL Limited for ₹60.09 crore via stock exchange on 1st October 2026
- HFCL Limited's FY 2025-26 turnover ₹4,528 crore, PAT ₹253 crore, net worth ₹4,727 crore; operates in telecom infrastructure
- Acquisition is not a related party transaction; no control or management stake intended; done at arm's length and required no regulatory approval
Original filing
Announcement under Regulation 30 (LODR)-Acquisition
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Maithan Alloys Ltd
- Acquisition / mergerMaithan Alloys acquires 0.65% stake in ESDS Software Solution for ₹113.37 crore
Other acquisition / merger filings this fortnight
- Acquisition / mergerKothari Petrochemicals LtdKothari Petrochemicals Ltd informs NSE on NCLT order for amalgamation scheme
- Acquisition / mergerVeranda LearningVeranda Learning announces Board constitution for J.K. Shah Commerce Education Limited
- Acquisition / mergerSai Parenteral'sSai Parenterals Limited completes acquisition of 60% stake in Prathyak Laboratories
- Acquisition / mergerDr Agarwals Eye Hospital LtdDr. Agarwal’s Eye Hospital files update on Scheme of Amalgamation with Dr. Agarwal’s Health Care
- Acquisition / mergerSunteck Realty LtdSunteck Realty subsidiary acquires approx. 4.5 acres land in Borivali West
- Acquisition / mergerDr Agarwal's HeaDr. Agarwal’s Health Care sanctioned NCLT merger with Dr. Agarwal’s Eye Hospital
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.